Prime solutions for cardiopulmonary bypass in neonates: Antioxidant capacity of prime based on albumin or fresh frozen plasma | Zendy

Jacek Molicki | Zendy; Anjo M. Draaisma | Zendy; Nicole Verbeet | Zendy; Rendel Munneke | Zendy; Hans A. Huysmans | Zendy; Mark G. Hazekamp | Zendy; Howard Berger | Zendy

Open Access

Prime solutions for cardiopulmonary bypass in neonates: Antioxidant capacity of prime based on albumin or fresh frozen plasma

Author(s) -

Jacek Molicki,

Anjo M. Draaisma,

Nicole Verbeet,

Rendel Munneke,

Hans A. Huysmans,

Mark G. Hazekamp,

Howard Berger

Publication year - 2001

Publication title -

journal of thoracic and cardiovascular surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.458

H-Index - 192

eISSN - 1085-8687

pISSN - 0022-5223

DOI - 10.1067/mtc.2001.115422

Subject(s) - ferric reducing ability of plasma , cardiopulmonary bypass , uric acid , antioxidant , albumin , fresh frozen plasma , ferric , ultrafiltration (renal) , hematocrit , medicine , oxidative stress , vitamin e , vitamin c , malondialdehyde , biochemistry , food science , chemistry , antioxidant capacity , organic chemistry , platelet

Oxidative damage and inflammation are believed to play an important role in postoperative complications after cardiopulmonary bypass. During bypass, a prime solution with a high antioxidant capacity may reduce the oxidative damage and inflammation. We investigated total antioxidant capacity and individual scavengers during the preparation of 2 different prime solutions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research